the CCAs were isolated by dissecting them free from the vagus nerve and sympathetic fibers. Aneurysm clips were gently placed around each vessel, and the CCAs were completely occluded for 10 minutes. At the end of the ischemic interval, the clips were released and blood flow was verified to resume through each artery. Eight nonischemic gerbils serving as sham-operated controls underwent the same surgical procedure, except that the CCAs were not occluded.
Preparation of Cell Suspensions From Fetal Human Brain
Fetal Human Tissue. The data presented are from two specimens of fetal human brains collected after elective termination of intrauterine pregnancies at 13 and 22 gestational weeks. At the time of collection, specimens were placed in HBSS supplemented with 100 U/ml penicillin, 100 g/ml streptomycin, 5 mM HEPES buffer, 50 g/ml gentamicin, 0.25 g/ml Fungizone, and 5 mM HEPES. All tissue was shipped to our institution within 24 hours of collection. All protocols were approved by the Human Investigation Committee at Wayne State University.
Tissue Dissociation. The specimens were rinsed several times with HBSS w/o to remove debris and blood. Next, the tissue was placed in a 10-cm plastic culture dish and the meninges were removed. The tissue was mechanically chopped into pieces 1 mm 3 or smaller by using a sterile razor blade. Tissue fragments were transferred to a 50-ml conical tube, rinsed with HBSS w/o and dissociated by using 0.25% trypsin at 37˚C for 20 minutes with shaking. The trypsin reaction was stopped with 2 ml of FBS and the solution was treated with 0.05 mg/ml of DNAse-I, Grade II (approximately 2000 U/mg) for 5 minutes. The tissue was centrifuged at low speed in a tabletop centrifuge (800 rpm), and the supernatant was discarded. One milligram of DNAse-I and 10 ml of HBSS were added to the pellet, and the tissue was triturated 30 to 40 times with a 10-ml serological pipette. The dissociated cells were filtered through a 20-m nylon mesh and placed in a 42-ml centrifuge tube containing 12 ml of Percoll and 1 ml DNAse-I. The volume was adjusted with HBSS w/o to fill the tube, resulting in a solution that was 28.5% Percoll. The solution was mixed by inversion and centrifuged at 10,000 G for 35 minutes at 10˚C in a fixedangle rotor. After centrifugation, the top 2 to 3 ml containing cellular debris was removed from the Percoll gradient. The next 38 ml of the gradient above the erythrocytes was collected, and the volume was adjusted to 50 ml with HBSS w/o and spun in a centrifuge to form a pellet. The supernatant was discarded, and the cells were resuspended in culture medium, as described later. Typical yields from 15 g of tissue fragments were 6 to 8 ϫ 10 7 cells with 80 to 90% viability by trypan blue exclusion.
In Vitro Culture of Human Fetal Brain Cells
For culturing, 2 ϫ 10 6 cells were seeded in 2 ml of Neurobasal medium supplemented with B27 and 5% FBS in six-well Primaria plates coated with 5 g/ml laminin. The cells were fixed with 4% paraformaldehyde after 3 or 7 days in vitro and processed for immunocytochemical studies. Some samples were used for RT-PCR detection of human nestin, GFAP, and ␤-tubulin.
Labeling Methods and Preparation of Cells for Transplantation
To enable the detection of cells in vivo, the ones used for transplantation were incubated with Hoechst nuclear dye (33342), a nuclear marker, at a concentration of 10 g/ml for 15 minutes at 37˚C in a 5% CO 2 -supplemented humidified atmosphere. This resulted in staining of all observable nuclei on fluorescent microscopy. The cells were washed three times with HBSS and finally resuspended in a small volume of Neurobasal medium supplemented with B27 and 5% FBS to yield a concentration of approximately 60,000 cells/l. Labeled control cells that had been killed by freezing and thawing and added to cells in vitro showed no transfer of the Hoechst marker to the live cells.
Transplantation Protocol
Except for five ischemic gerbils and two sham-operated controls, all other animals were immunosuppressed with daily injections of 10 mg/kg cyclosporin, beginning 1 day before transplantation. The transplantation procedure was performed 1 week after induction of cerebral ischemia. Stereotactically guided surgery was performed after induction of ketamine (50 mg/ml) and rompun (5 mg/ml) anesthesia. Following exposure of the cortex, 1 l of cell suspension was injected into the CA1 field of the dorsal hippocampal formation 2.1 mm posterior to and 2 mm lateral to bregma and 2 mm ventral to the cortical surface by using a Hamilton syringe. In the contralateral side we injected 1 l of the medium used to suspend the cells. The coordinates were based on a stereotactic atlas of the adult Mongolian gerbil brain. 23 
Tissue Processing
At 1 week after transplantation, the gerbils were killed with 5% chloral hydrate and transcardially perfused with 0.1 M PBS, followed by a 5-minute rapid fixation with 4% paraformaldehyde in 0.1 M PBS. The brains were removed and placed in 4% paraformaldehyde overnight, before being transferred to 25% sucrose in PBS. Coronal sections were cut on a vibratome at a thickness of 50 m.
Immunocytochemical Studies
Before processing for intracellular antigens such as GFAP, ␤-tubulin III, and MAP-2ab, all tissue and cultured cells were permeabilized with 0.1% Triton X-100 for 7 minutes at room temperature. Ten percent normal goat serum, which was added to the culture and incubated for 30 minutes at room temperature, was used for blocking nonspecific sites. All primary antibodies were incubated overnight at 4˚C. The primary antibodies used were directed against GFAP (1:100, polyclonal rabbit), ␤-tubulin III (1:100), MAP-2ab (1:100, monoclonal mouse), CD68 (1:200), von Willebrand factor (1:200), human fibroblast surface protein (1:200), and A007 (hybridoma supernatant, a monoclonal oligodendrocyte antibody that recognizes an oligodendrocyte surface sulfatide 6 ). It has been shown that A007 is similar or identical to O4 with respect to its antigenic specificity. 6 Secondary antibodies included biotinylated forms of the respective antibodies used at concentrations of 1:50 and incubated for 1 hour at room temperature, followed by 1:50 Cy3-or Cy2-conjugated streptavidin incubated for 1 hour at room temperature.
Confocal Microscopy
Localization of Hoechst-positive cells in vivo, as well as colocalization of Hoechst dye with neuronal and glial markers, was conducted with confocal microscopy by using a laser scanning microscope.
Reverse Transcriptase Polymerase Chain Reaction
Total cellular RNA from astrocyte cultures was prepared using an RNA isolation kit. Fifteen micrograms of purified total RNA was used for complementary DNA synthesis. The RT was performed in a 30-l volume at 37˚C by using first-strand beads and oligodT primers. Ten microliters of the RT reaction was used for PCR. The primers used for human nestin, 12 GFAP, and ␤-tubulin were as follows: nestin, sense 5Ј-AGAGGGGAATTCCTGGAG-3Ј and antisense 5Ј-CTGAGGACCAGGACTCTCTA-3Ј; GFAP, sense 5Ј-CGCTGGCTGCTGAGCTGAAC-3Ј and antisense 5Ј-CAG-CCTCAGGTTGGTTTCA-3Ј; ␤-tubulin, sense 5Ј-GGGGCGCAT-TCCAACCTT-3Ј and antisense 5Ј-AGCTCGGCGCCCTCTGTG-TAGT-3Ј. The reaction mixture was heated to 94˚C for 1 minute, followed by 30 cycles consisting of 1 minute of denaturation and annealing at 94˚C and 72˚C, respectively, and a 1-minute elongation step at 55˚C. A final 10-minute extension was performed at 72˚C after completion of the last cycle. All PCRs were performed in a thermal cycler. Amplification reactions were accomplished with Taq DNA polymerase. The RT-PCR products were electrophoresed and visualized using ethidium bromide staining, and the sizes of the RT-PCR products were confirmed by comparison with a 100-bp ladder run in parallel on the same gel. The amount of complementary DNA used in each sample was standardized to the level of the GAPDH gene; GAPDH primer sense sequence CCATGGAGAAGGCTG-GGGCT, antisense CAAAGTTGTCATGGATGACC. The expected DNA fragment lengths for GFAP, ␤-tubulin, and human nestin were as follows: 236 bp, 440 bp, and 490 bp, respectively.
Sources of Supplies and Equipment
The trypsin was supplied by Life Technologies, Grand Island, NY. The Grade II DNAse-I was obtained from Boehringer Mannheim Biochemicals, Indianapolis, IN. The Percoll, Hoechst 33342 nuclear dye, GFAP, ␤-tubulin III, MAP-2ab, and human fibroblast surface protein were purchased from Sigma Chemical Co., St. Louis, MO. The fixed-angle rotor centrifuge (model JA-20) was acquired from Beckman-Coulter, Inc., Fullerton, CA. The Neurobasal medium was provided by Gibco-BRL, Gaithersburg, MD. The CD68 was purchased from Accurate Chemical and Scientific Corp., Westbury, NY, and the von Willebrand factor from Dako Corp., Carpinteria, CA. The biotinylated antibodies were acquired from Vector Laboratories, Burlingame, CA, and the Cy3-and Cy2-conjugated streptavidin from Jackson ImmunoResearch, West Grove, PA.
The laser scanning microscope (model LSM 310) was obtained from Zeiss, Oberkochen, Germany. The TRI-REAGENT RNA isolation kit was supplied by Molecular Research Center, Cincinnati, OH. The Ready To Go first-strand beads used in RT were obtained from Pharmacia Biotech, Piscataway, NJ. The primers for human nestin, GFAP, and ␤-tubulin were synthesized by Gibco-BRL, which also provided the Taq DNA polymerase. The thermal cycler was purchased from Perkin-Elmer, Norwalk, CT.
Results

Histological Evaluation of Postischemic Neuronal Damage
Hematoxylin and eosin staining of histological sections revealed that the host pyramidal neurons in the CA1 field of the dorsal hippocampal formation were intact in the sham-operated gerbils (Fig. 1A) . Bilateral degeneration of the host's CA1 neurons had occurred in the ischemic gerbils, with preservation of cells in the dentate gyrus and CA3-4 region (Fig. 1B-D) . These results were consistent with previously published reports on the pattern and degree of neuronal loss in the ischemic gerbil hippocampus. 20 Cyclosporin had no effect on the host's neuronal loss.
Cell Survival, Migration, and Differentiation After Transplantation to Ischemic Gerbil Hippocampus
In ischemic and nonischemic animals that had not been immunosuppressed, no transplanted cells survived. In contrast, in animals that had received daily injections of cyclosporin, transplanted cells (with Hoechst-positive nuclei that appeared blue) were observed in the transplantation site, as well as in other adjacent sites to which the cells had migrated (Fig. 2) . Transplanted cells were seen in the CA1 region of both the ischemic and sham-operated gerbils (Figs. 2B and 2D) and were indistinguishable from each other. In both nonischemic and ischemic animals, some cells had migrated to the nearby dentate gyrus (Figs. 2E and 2F ) or corpus callosum, with no preferential direction, to a distance of approximately 1 mm from the graft core. Cells present in the corpus callosum often migrated a considerable distance away from the original transplantation site. The side that had been injected with vehicle only revealed no Hoechst staining of the host's found either within or in the immediate vicinity of the needle track scar (Figs. 2G and 2H) .
Rarely, transplanted cells expressed neuron-specific (MAP-2ab or ␤-tubulin III) antigens (Fig. 3) . The rarity of these cells did not allow us to make meaningful regional or group comparisons. In general, there were no significant differences in the survival, migration, or differentiation pattern of transplanted cells in the ischemic compared with control animals. Transplants from both cell cultures (13-week and 22-week fetal brain) were indistinguishable in terms of graft survival, migrational patterns, and phenotypic differentiation of the transplanted cells. Antibody staining for astrocyte-(GFAP), oligodendrocyte-(A007), microglial-(CD 68), endothelium-(von Willebrand factor), and fibroblast-(human fibroblast surface protein antigens) specific antigens was negative.
In Vitro Characteristics of the Transplanted Cells
Initially, the cultured cells derived from the fetal human brain suspensions used in the transplantation study appeared small, undifferentiated, and round. Within 24 hours the cells adhered to the laminin substrate, and over the course of 3 to 7 days began to differentiate and express neuron-specific and astrocyte-specific antigens (Fig.  4) . The RT-PCR of the cultured cells for human nestin mRNA, a marker of neuroepithelial stem cells, 22 revealed that the cells expressed nestin mRNA on Days 0 to 1 in vitro (Fig. 5 ), yet this expression had nearly disappeared by Day 2. In contrast, mRNA expression of GFAP, an astrocyte-specific antigen, and ␤-tubulin III, a marker of young neurons, 4, 5 began by Day 3 and persisted into Day 7 (Fig. 6 ). These data, taken together, indicate that the initial population of cells that were used for transplantation consisted mostly of stem cells that gradually differentiated into neurons and astrocytes in culture. Antibody staining for oligodendrocytes was rarely positive. Immunostaining for microglia-, endothelium-, and fibroblast-specific antigens was negative.
Discussion
Animal Models of Cerebral Ischemia
Neural transplantation offers hope for reducing the catastrophic effects of cerebrovascular ischemia. There is growing interest in fetal tissue as a resource for experimental neural transplantation studies in animal models of cerebral ischemia. Most studies have been performed in adult rats, in which focal or transient occlusion of the middle cerebral artery is used. 9 Allogeneic fetal transplanted cell types have included the following: striatal cells, 10 hippocampal cells, 17, 24, 32, 33 and cortical cells. 16 The transplanted fetal cells have been demonstrated to survive and integrate with the host tissue and to reduce the ischemiarelated behavioral deficits in the short term. 9 In addition to allogeneic tissue, implants of cells derived from other species (xenografts) have also been studied in the rat cerebral ischemia model. These cell types include human embryonal carcinoma-derived neurons 10 and immortalized hippocampal neuroepithelial cells derived from embryonic mouse. 30 Fetal gerbil hippocampal cells, when transplanted to the ischemic adult gerbil hippocampus, have also been shown to survive, integrate with the host brain, and ameliorate an ischemically induced spatial memory deficit. 26 
Cerebral Blood Flow and Metabolism in the CA1 Sector After Ischemic Injury in the Gerbil Brain
Experiments on regional cerebral blood flow, glucose utilization, and ATP levels in gerbils subjected to 5 minutes of bilateral CCA occlusion have shown that at 4 days of recirculation, cerebral blood flow remains unchanged in the CA1 sector, yet there is a reduction in glucose utilization and a 70% reduction in ATP levels compared with control animals. 25 Another study in which the same model was used has shown that after 7 days of recirculation, the density of perfused capillaries in the postischemic CA1 sector is less than 30% and the circulating blood volume is less than 50% of that in the cerebral cortex. 18 Taken together, these studies show that 1 week after transient forebrain ischemia, the CA1 sector is poorly perfused and hypometabolic. Based on a metabolic perspective, various mechanisms have been proposed to explain the selective vulnerability of the pyramidal neurons of the CA1 sector after transient global ischemia. One possible triggering mechanism might be low levels of the mitochondrial enzyme succinate dehydrogenase in the pyramidal cell layer of the CA1 sector. 21 Other possible mechanisms include a derangement of mitochondrial DNA expression in the CA1 neurons at the early stage of perfusion, which is aggravated over time, 1 as well as a disturbance in ATP binding of multifunctional calcium-and calmodulin-dependent protein kinase II, a major calcium signal-transducing enzyme.
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There are several potential advantages of transplantation of individual cells compared with blocs of tissue into a poorly perfused and hypometabolic area. First, because the cells are completely surrounded by the host environment, they are more likely to respond to host-initiated cues designed to facilitate repair. Second, they are relatively tolerant of oxygen deprivation and thus are more likely to survive in an anaerobic environment. Last, suspended cells have additional mobility in the graft site and are better exposed to the soluble factors in or adjacent to the transplant site. 34 
Transplanted Human Fetal Cells
The possible use of human fetal tissue in clinical trials of transplantation for cerebrovascular disease requires further knowledge about several crucial factors that influence the efficacy of the intracerebral grafts. These include the following: the mode of donor tissue preparation, the method of grafting, the state of the host tissue, the location of the transplantation site, and the immune status of the host. 29 Recently, neural progenitor cells obtained from fetal human forebrain and grown in the presence of basic fibroblast growth factor, epidermal growth factor, and leukemia inhibitory factor were transplanted into the subventricular zone, hippocampus, and striatum of normal adult rats. 13 Immunohistochemical analysis of the brains revealed that the transplanted cells exhibited a remarkable capacity for migration, integration into the host tissue, and site-specific differentiation. This is the first report, to our knowledge, of transplantation of nontransformed primary human fetal brain cells into an ischemic model. Our data show that these cells are capable of short-term survival in the ischemic adult gerbil hippocampus. The nondirected migration pattern of the transplanted cells is consistent with the previously reported data on transplanted human fetal cells in the rat brain, in which cells with gliallike features exhibited substantial migration within the striatum, and cells with neuronal phenotypes remained close to the implantation site. 13 The significant migration capacity of transplanted cells within white matter tracts such as the corpus callosum has recently been used as the basis of a method to deliver therapeutic genes in an experimental brain tumor model. 8 The lack of differentiation into mature cell types in vivo within 1 week of transplantation stands in contrast with the relatively quick differentiation (within 3 days in vitro) of nearly all the stem cells in culture in our study. Longer survival periods are necessary to determine whether these transplanted cells will differentiate in the adult gerbil brain. The host's environmental cues, such as growth factors and extracellular matrix proteins, as well as the grafted cells' receptors for these factors, probably play major roles in cell survival and differentiation posttransplantation. 28, 32 The fact that both vehicle-and cell-injected transplantation sites shared identical needle track scars is similar to findings in a previously published article on intracerebral transplantation. 15 The nature and distribution of astroglia and developmentally regulated extracellular matrix molecules between donor and host regions may affect the survival of the transplanted cells in the scarred area. 15 The finding that human fetal neural stem cells respond to specific extracellular cues present in various regions of the rat brain, and thus differentiate into the neuronal phenotype normally present in the host transplantation site, 13 coupled with the fact that presynaptic terminals containing synaptic vesicles persist in a gliotic scar following ischemic damage, 19 indicates that, after neural transplantation, neuronal replacement and establishment of synaptic connections with host circuitry might be possible after cerebral ischemia. Our data indicate that, after 1 week, an ischemic cerebral lesion is permissive to fetal human brain cell survival. This is consistent with other reports of studies in which allogeneic intracerebral transplants have been used. 16, 24 Recently, CNS precursors grown in vitro were shown to form electrically active and functionally connected neurons on transplantation into the brains of rats. 3 Besides neuronal replacement, neural transplantation promises to protect dying host cells and reduce gliosis by delivering necessary genes and gene products.
Effect of Cyclosporin
The beneficial effect of cyclosporin on neuronal apoptosis has been reported before. 31 It is possible that the cell survival phenomenon observed in our study represents the dual effect of immunosuppression and cell protection by cyclosporin.
Future Investigations
In our laboratory we have been able to grow human fetal neural stem cells under the influence of growth factors, cryopreserve them, and transfect them with a foreign transgene (data not shown). Genetically modified fibroblasts producing nerve growth factor, when transplanted into the ischemic brain of adult rats, have been shown to protect the hippocampal neurons from cell death. 27 The antiapoptic gene BCL-2, when selectively introduced into the CA1 region of the ischemic gerbil hippocampus, has also been shown to protect hippocampal neurons from undergoing apoptosis. 2 For intracerebral transplantation purposes, an expandable population of human fetal neural stem cells, which can be transfected to produce growth factors or antiapoptic genes, might be an alternative to implantation of primary human fetal brain tissue or transformed cell lines, which have the potential to become tumorigenic.
Conclusions
In summary, xenotransplanted human fetal brain cells are capable of surviving in an ischemic lesion after 1 week. The immune status of the host and the proximity to the needle track scar play major roles in the survival of these cells. Within this time period, the majority of the transplanted cells do not differentiate into mature cell types normally found in CNS tissue. This model might be beneficial for the development of systems for cell replacement and/or gene transfer for the treatment of cerebrovascular ischemia in humans.
